Introduction
Gestational diabetes (GDM) is defined as carbohydrate intolerance of variable severity with onset or first recognition during pregnancy [1] . Women with a history of GDM are at increased risk of future diabetes; predominately type 2.Theirchildren are at increased risk of obesity, glucose intolerance, and diabetes in late adolescence and young adulthood [2] ,and thus, GDM offers an important opportunity for diagnosis and implementation of clinical strategies for diabetes prevention. The prevalence of GDM varies widely based on the diagnostic criteria used and the ethnic group studied [3] .In the Indian context, screening is essential in all pregnant women as the Indian women have eleven fold increased risk of developing glucose intolerance during pregnancy compared to Caucasian women [3] . Among ethnic groups in south Asian countries, the Indian women have highest frequency of GDM. Recent data shows 16.55 % prevalence of GDM in India [4] .
In 1999, the World Health Organization (WHO) introduced criteria for diagnosis of GDM on the basis of a 2-h venous plasma glucose (VPG) cut-off value of 140 mg/dl (7.8 mmol/l), after the administration of 75 g of glucose [5] . The WHO 1999 criteria have become popular, particularly in developing countries, because it is simpler than the two-step procedure [6] . In 2010, The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [7] , a large-scale (25,000 pregnant women) multinational cohort study, demonstrated that risk of adverse maternal, fetal, and neonatal outcomes continuously increased as a function of maternal glycemia at 24-28 weeks, even within ranges previously considered normal for pregnancy. The IADPSG defined diagnostic cut points for GDM as the average glucose values (fasting, 1-h, and 2-h PG) in the HAPO study at which odds for adverse outcomes reached 1.75 times the estimated odds of these outcomes at the mean glucose levels of the study population. Based on the HAPO study, IADPSG proposed a new set of criteria which has since been adopted in many countries. Recently, the WHO has also adopted the IADPSG criteria [8] .In the 2011 Standards of Care [9] , the ADA for the first time recommended that all pregnant women not known to have prior diabetes undergo a 75-g OGTT at 24-28 weeks of gestation, based on the recommendation of IADPSG [10] . Thus, there is still no consensus on the screening and diagnostic criteria of GDM in India.
II. Materials And Methods
This is a retrospective study conducted from January 2015 to June 2016 at Command Hospital, Air Force, Bangalore. Data of the patients who delivered at the hospital were collected and studied. All pregnant women with estimated gestational age between 24th and 28th weeks attending ANC clinic during the study
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DOI: 10.9790/0853-1603121215 www.iosrjournals.org 13 | Page period were included in the study.IADPSG and DIPSI criteria were used for the diagnosis of GDM. Women who were known diabetics, or who were suffering from any chronic illness (CRF, autoimmune disorder etc.) were excluded from the study. All these women were subjected to 75 gm OGTT between 24 to 28 weeks of gestation as per IADPSG guidelinesand data was analysed as per both IADPSG (use of 2 hour 75 g OGTT, any one deranged value of fasting plasma glucose > 92, 1hour > 180 and 2 hour >153 as diagnosis of GDM) and DIPSI (one step procedure, between 24-28 weeks, diagnostic criteria being 2 hour plasma glucose is >140 mg/dl) guidelines. These patients diagnosed as GDM were further followed up and divided into two categories based on their response to treatment, that is, MNT alone or requirement of further pharmacotherapy (OHA/ Insulin). Those requiring additional pharmacotherapy were considered to have relatively more severe GDM.
Observations and results
A total of 1470patients who fulfilled the inclusion criteria were selected for the study. The total number of patients diagnosed as GDM as per IADPSG and DIPSI criteria is shown in Table 1 .
Number of patients diagnosed as GDM as per IADPSG and DIPSI criteria (Table 1)
The difference between the diagnostic rates of IADPSG and DIPSI was significant at p <.01.
The total number of patients diagnosed as GDM by both IADPSG and DIPSI criteria was only 2.7% as shown in Table 2 . Table 3 .
Number of patients diagnosed as GDM by both IADPSG and DIPSI criteria (
(Number of patients diagnosed to be GDM based on various abnormal values Maximum number of cases of GDM (8.43 %) was detected by fasting values alone. Non fasting values were able to diagnose only 3.4% of cases. This was also significant at p <.01.
The response to therapy among the various sub groups was further analysed and divided into whether treated by MNT alone or requiring pharmacotherapy (OHA/ Insulin) as shown in Table 4 . 
Response to therapy among the various sub groups (

III. Discussion
Glucose intolerance during pregnancy can be of varying severity. Early diagnosis, adequate treatment and follow-up are vital in successfully managing the patients as GDM is associated with high incidence of perinatal mortality and morbidity. In our study 11.97% were diagnosed as GDM as per IADPSG criteria and 3.94% as per DIPSI criteria. In the study conducted by Rajesh Rajput et al. at Post graduate institute of Medical Sciences , Haryana , the incidence was 7.1 % as per ADA criteria (2 or more values required) but if only fasting single value was used then incidence was 9.06% (55/607) [11] . The study conducted by a Kalra P et al. at Jodhpur, Rajasthanshowed that the incidence was 6.6 % as per DIPSI criteria [12] . In the study conducted by Wahi P. et al. at Jammu and Kashmir showed that the incidence of GDM was 6.5 % as per DIPSI criteria [13] .
V.Balaji et al conducted a study at Government Maternity Hospital,Chennai,where the incidence of GDM was 18.9 % as per WHO criteria [14] .In a study by Nayak et al at Pondicherry Institute of Medical Sciences,Pondicherry, the incidence of GDM was 27 % as per IADPSG criteria and if only fasting value was used then incidence was 23% [15] . V Mohan et al compared DIPSI with IADPSG for diagnosis of GDM. They had incidence of 4.2% with DIPSI and 10.3% with IADPSG [16] . A comparison of these studies is shown in Table 5 . In our study, the total number of patients diagnosed to be GDM by IADPSGwas 11.97%, which is comparable to the study by V Mohan et al [16] . By DIPSI criteria, using only the 2hr value, GDM was diagnosed in 3.94% cases. This is also comparable to other studies [12, 13, and 16] . The diagnostic rate of GDM based only on the fasting value was 8.43%. This also correlates with the findings of other studies [11, 16] . Our study shows thatFBG value has the highest diagnostic rate for GDM which is being completely ignored by DIPSI.We further assessed the severity of GDM by dividing the patients into two groups, one on MNT alone and the other requiring some form of pharmacotherapy. We found that 27.4% of patients diagnosed as GDM by fasting value needed pharmacotherapy while 57.69% of patients diagnosed by non-fasting value required pharmacotherapy. The difference in the use of pharmacotherapy in these two groups was not significant.
Comparison of various studies (
IV. Conclusion
Our study is unique in that the patients included in the studywere from all parts of the country and not localised to one ethnicity or community. IADPSG criteria were able to diagnose GDM at comparable rates but DIPSI was not. We suggest that IADPSG criteria may be better suited for implementation pan India rather than those proposed by DIPSI.Our study concludes that (a) IADPSG criteria detects more number of GDM cases than DIPSI, (b) FBG value alone can diagnose 8.43% of GDM which is more than the number detected by 2 hr value, and (c) the severity of GDM in patients diagnosed by fasting value is comparable to that with non-fasting values and cannot be ignored.
